Drs. Koen Van Besien, Jingmei Hsu, and Marshall Glesby have led a clinical trial involving a patient living with HIV who has now been free of the virus for 14 months.
Dr. Cristofanilli's many scientific advances in the field of breast cancer include novel biomarkers (endocrine), findings on circulating tumor cells, and drug development with a focus on endocrine therapy.
The award will support Dr. Landau’s development of novel technology to study clonal mosaicism in normal tissues. This research will open a critical window into the earliest stages of cancer formation.
Lectures were provided by WDOM faculty and keynote speaker, Dr. Drew Weissman, who played a major role in critical discoveries that allowed for the mRNA platform to be used in developing vaccines against SARS-CoV.
Beloved by patients, colleagues, trainees, and staff alike, Dr. Ruggiero is retiring after a 44-year career at Weill Cornell Medicine.
Drs. Gregory Sonnenberg, Jeremy Goc, and Manish Shah have discovered that innate lymphoid cells protect against colorectal cancer, in part, by helping to maintain a healthy dialogue between the immune system and gut microbes.
On Friday, September 24, 2021, the Second Annual Meeting on Advances on Nuclear Topology and 3D Chromatin Architecture in Cancer will be held as a FREE virtual symposium.
Initiated in 2002, the award is given to fellows within the Weill Department of Medicine who have performed outstanding research. This year's finalists were presented at Medicine Grand Rounds on June 23.
The exciting new algorithm, MethSig, analyzes the thousands of DNA methylation changes detected in tumor cells and infers which ones are likely driving tumor growth.
Dr. Leandro Cerchietti and colleagues have published a paper in Cancer Discovery that has revealed a critical connection between lymphoma tumors and their microenvironments, which consist of different ecosystems of cells and treatment responsiveness.
